Extraordinary Shareholder’s Meeting - January 25, 2021

Pr. Scott Friedman

Member of the Scientific Advisory Board

Professor of medicine and pharmacology, he is the Chief of the Division of Liver Diseases and Director of the Liver Research Laboratory at the Mount Sinai School of Medicine in New York. His work in the field of fibrosis associated with chronic liver diseases is internationally recognized.

He is the assistant editor-in-chief of the Hepatology review and is on the editorial board of the Journal of Gastroenterolgy and Hepatology.